Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Adenoid Cystic Carcinoma|Non-hodgkin Lymphoma|Glomus Tumor, Malignant|Hepatocellular Carcinoma|Osteosarcoma|T-ALL
Interventions: DRUG: CB-103
Sponsor: Cellestia Biotech AG